Assessment of subchronic oral aluminum exposure and metformin co-administration on spatial memory and neuroinflammation in rats
Ars Pharmaceutica (Internet) · 20.06.2026 · 67 (3) · 354-363
DOI: 10.30827/ars.v67i3.36709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ars Pharmaceutica (Internet), online erschienen am 20.06.2026. Verfasst von Kadir Bal und 3 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
Aluminium is a ubiquitous neurotoxin associated with Alzheimer’s disease pathology. In this study, we aimed to investigate the effects of subchronic oral aluminium administration on spatial memory and neuroinflammatory markers, as well as the potential impact of concurrent metformin administration on these changes.
Method
Wistar albino rats were divided into six groups: Control, Al (70 mg/kg via drinking water), Metformin (100 and 200 mg/kg i.p.), and Al + Metformin 100 and 200 mg/kg for 49 days. Spatial learning and memory were assessed using the Morris Water Maze, while locomotor activity was evaluated via Open Field tests. Hippocampal tissues were analysed for amyloid-β plaques, morphology, and inflammatory markers (TNF-α, IL-1β, IL-6, IL-8, Amyloid-β1-42) via ELISA and histology.
Results
Results indicated no significant deficits in spatial memory or locomotor activity among groups. Histopathological examination revealed no amyloid deposition or significant morphological changes. Molecular analysis showed no consistent alteration in inflammatory markers, except for an isolated increase in IL-1β in the high-dose metformin co-treated group.
Conclusions
The oral administration of 70 mg/kg Aluminum for 49 days did not elicit detectable neurotoxicity, likely due to limited gastrointestinal absorption; consequently, the neuroprotective potential of metformin could not be effectively evaluated. These findings suggest that subchronic oral Al exposure via drinking water may be an insensitive model for inducing Alzheimer’s Disease-like pathology in rats, highlighting the necessity for alternative administration routes or extended exposure durations in future toxicological assessments.
Zitieren
APA
Bal, K., Avkıran, M., Erdoğan, E. G., & Topuz, R. D. (2026). Assessment of subchronic oral aluminum exposure and metformin co-administration on spatial memory and neuroinflammation in rats. Ars Pharmaceutica (Internet), 67(3), 354-363. https://doi.org/10.30827/ars.v67i3.36709
Vancouver
Bal K, Avkıran M, Erdoğan EG, Topuz RD. Assessment of subchronic oral aluminum exposure and metformin co-administration on spatial memory and neuroinflammation in rats. Ars Pharmaceutica (Internet). 2026;67(3):354-363. doi:10.30827/ars.v67i3.36709
BibTeX
@article{Bal2026,
author = {Bal, Kadir and Avkıran, Mert and Erdoğan, Ezgi Genç and Topuz, Ruhan Deniz},
title = {Assessment of subchronic oral aluminum exposure and metformin co-administration on spatial memory and neuroinflammation in rats},
journal = {Ars Pharmaceutica (Internet)},
year = {2026},
volume = {67},
number = {3},
pages = {354--363},
doi = {10.30827/ars.v67i3.36709}
}
EUVIMED